CLVSQ — Clovis Oncology Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $2.17m
- $604.23m
- $148.76m
Brief: Clovis Oncology Presents Data From Triton3 Phase 3 Trial Of Rubraca® (Rucaparib) At The 29Th Annual Prostate Cancer Foundation Scientific Retreat
U.S. STOCKS ON THE MOVE-Silver miners, KBR, Regeneron
U.S. STOCKS ON THE MOVE-Coinbase, Peloton, Viasat
Clovis Oncology up after prostate cancer drug meets main goal in late-stage study
Brief: Triton3 Phase 3 Trial Of Rubraca Meets Primary Endpoint In Men With A Type of Prostate Cancer
U.S. STOCKS ON THE MOVE-Freyr Battery, General Mills, Coty, ShiftPixy
Clovis up on supply deal for component related to cancer therapy
Brief: Clovis Oncology, Isotopia Announce Lutetium-177 Clinical Supply Agreement
Brief: Clovis Oncology Submits Applications For Rubraca Label Expansion In The US And European Union
U.S. STOCKS ON THE MOVE-Perrigo, FG Financial, Alector
U.S. STOCKS ON THE MOVE-Metal miners, Rambus, Nuwellis
U.S. STOCKS ON THE MOVE-Titan Medical, Gold miners, Relay Therapeutics
Clovis rises after promising data in ovarian cancer drug trial
U.S. STOCKS ON THE MOVE-Tiptree, Viatris, EV charging stocks
U.S. STOCKS ON THE MOVE-Elanco, Ceco, Monday.com
Clovis Oncology Inc reports results for the quarter ended in June - Earnings Summary
Clovis Oncology slides on disappointing results
Brief: Clovis Oncology Q2 Loss Per Share $0.50
Brief: EMA Recommends Restricting Use Of Cancer Medicine Rubraca